# Promising Outlook for Thailand’s Pharmaceutical Industry

- Link: https://www.thailand-business-news.com/health/226675-promising-outlook-for-thailands-pharmaceutical-industry
- Published: 2025-07-03T05:48:00+07:00
- Author: News Desk

**Thailand’s pharmaceutical market is expected to experience consistent growth, 
fueled by robust local production and strong government backing, even amidst economic
challenges. By 2034, generic drugs are anticipated to account for 50% of the market.**

### Key View

 * We anticipate steady growth in Thailand’s pharmaceutical market, even amid the
   country’s broader economic slowdown.
 * The government’s focus on local production will create opportunities for domestic
   drugmakers, while regulatory challenges may impact market entry for foreign drugmakers.
 * By 2034, the generic market segment will account for around 50% of Thailand’s
   pharmaceutical market. 

We anticipate steady growth in Thailand’s pharmaceutical market, even amid the broader
economic slowdown. According to our Country Risk team, Thailand’s real GDP growth
decelerated slightly from 3.2% year-on-year in Q4 2024 to 3.1% in Q1 2025. Despite
this moderated economic expansion, in June 2025, Thailand’s House of Representatives
approved the fiscal year 2026 budget, allocating THB265bn (USD8.1bn) to the National
Health Security Office (NHSO). This allocation underscores the government’s commitment
to bolstering national healthcare and ensuring widespread access to medical services.

ADVERTISEMENT

The NHSO will use the budget to expand the National Essential Medicines List to 
include advanced treatments and launch public health campaigns such as ‘Healthy 
Thais, Free from Non-Communicable Diseases’, aimed at reducing chronic disease burden.
The presence of robust funds is expected to underpin the pharmaceutical sector growth.
We forecast Thailand’s pharmaceutical sales will reach THB214bn (USD6.0bn) in 2024
and THB275bn (USD8.3bn) by 2029, reflecting a five-year CAGR of 5.2% in local currency
terms and 6.4% in US dollar terms. 

Thailand’s pharmaceutical sector is facing a stable outlook despite ongoing economic
constraints and regulatory challenges. With the country’s expanding healthcare needs
and a growing demand for innovative therapies, the industry remains resilient. This
stability is bolstered by the government’s initiatives to enhance local manufacturing
capabilities and foster partnerships with international pharmaceutical companies,
ensuring a steady pipeline of essential medications.

### Related**Posts**

###  󠀁[TAT highlights “Healing is the New Luxury” at the Tourism Expo Japan 2026](https://www.thailand-business-news.com/health/331124-tat-highlights-healing-is-the-new-luxury-at-the-tourism-expo-japan-2026)󠁿

###  󠀁[Thailand’s Healthcare Expansion Strategy](https://www.thailand-business-news.com/health/327785-thailands-healthcare-expansion-strategy)󠁿

###  󠀁[Thailand Boosts Herbal SMEs to Tap Global Wellness Market](https://www.thailand-business-news.com/health/323058-thailand-boosts-herbal-smes-to-tap-global-wellness-market)󠁿

###  󠀁[ASEAN Culture Collection Swab Market Growth, Trends, and Outlook 2026–2035](https://www.thailand-business-news.com/asean/312933-asean-culture-collection-swab-market-growth-trends-and-outlook-2026-2035)󠁿

However, the sector is not without its hurdles. Economic uncertainties, including
fluctuations in the global market and inflationary pressures, impose challenges 
on production costs and pricing strategies. Additionally, regulatory complexities
can create barriers for new entrants and slow down the approval processes for new
drugs. Nevertheless, the Thai government has taken steps to streamline these regulations,
making it easier for companies to navigate the approval landscape.

In conclusion, while Thailand’s pharmaceutical industry contends with economic and
regulatory headwinds, its strategic initiatives and growing market demand contribute
to a positive outlook. Continued investment in innovation and a collaborative approach
with international partners will further enhance the sector’s stability and growth
in the coming years.
[Read More](https://www.fitchsolutions.com/bmi/pharmaceuticals/stable-outlook-thailands-pharmaceutical-sector-amid-economic-constraints-and-regulatory-challenges-12-06-2025)